OracleORCLBUY ON WEAKNESSJul 12, 2013Stock price when the opinion was issued
As of Sep 15, 2026. Market Open.
They just reported: 30% topline revenue growth, free cash flow a lot better than expected, though still negative because they're investing in the business. They did not announce new capex plans. Their current default swaps are starting to make a difference, from 215 bps a few weeks ago, and now at 181 bps. Lots to like, but shares are down because interest rates are up in recent days. You can buy on weakness now. Their capex spend will remain an overhang, though.
Hyperscaler. Ran into issues with a series of announcements that amounted to running up a bill of $80B. So then they had to get financing and raise $20B in stock issuance. Reports next week. Price target of $258, and you won't find a much longer runway. Yield is 1.35%.
(Analysts’ price target is $245.49)Generated $32B of operating cashflow last year. FCF is negative because they spent roughly $56B building AI data centres. Investors are willing to tolerate that spending because of extraordinary demand. Wouldn't expect a FCF reversal while the buildout continues, but those new data centres will produce revenue.
Rebound potential. Wait and see, earnings next week. She has only a 1/2 position now, and will see what the earnings report says.
Have good products but are up against enterprise spending budgets. Software is not a priority in the same way that data analytics, big data or storage are. They have a product on the enterprise side that has kind of missed the sales targets they originally planned. Made excuses rather than explanations and created doubt in investors’ minds. Missed the boat on a number of things. Senses that they are building the balance sheet in order to do something. Would wait for a better entry point.